Page last updated: 2024-10-30

methazolamide and Spondylitis, Ankylosing

methazolamide has been researched along with Spondylitis, Ankylosing in 2 studies

Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.

Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.

Research Excerpts

ExcerptRelevanceReference
"Methazolamide is a carbonic anhydrase (CA) inhibitor with satisfactory safety."1.91Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA. ( Gao, P; Liang, W; Liu, Q; Sun, T; Wang, M; Yan, X, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sun, T1
Wang, M1
Liang, W1
Gao, P1
Liu, Q1
Yan, X2
Chang, X1
Zhang, Y1

Other Studies

2 other studies available for methazolamide and Spondylitis, Ankylosing

ArticleYear
Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA.
    Scientific reports, 2023, 09-16, Volume: 13, Issue:1

    Topics: Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Molecular Docking Simulation; Network Pharmaco

2023
Treat ankylosing spondylitis with methazolamide.
    International journal of medical sciences, 2011, Volume: 8, Issue:5

    Topics: Administration, Oral; Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Spondylitis, Ankylosing

2011